跳至主要内容
临床试验/NCT05772676
NCT05772676进行中(未招募)4 期

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Gastric Sleeve Surgery

Hospital General Tlahuac1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2022年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
400
试验地点
1
主要终点
Patient's postoperative nausea and vomiting evaluation at 0 hrs (Rhodes index)

研究概览

简要总结

The purpose of this study is to assess the efficacy of Aprepitant + standard antiemetic regimen in reducing postoperative nausea and vomiting after laparoscopic gastric sleeve versus placebo + standard antiemetic regimen

详细描述

After being informed about the study, all patients who provide written informed consent and meet the eligibility requirements will be randomized in a triple-blind manner (participant, evaluator, and investigator) in a 1:1 ratio to Aprepitant (80 or 125 mg) + standard antiemetic regimen (once two hours before surgery) or placebo + standard antiemetic regimen(once two hours before surgery).

The standard antiemetic regimen will be Ondansetron 8 mg + Metoclopramide 10 mg + Dexamethasone 8 mg

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Triple-blinded, 1:1ratio to Aprepitant or placebo

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 65 years old.
  • Non-smokers.
  • Obesity with BMI > 30 kg/m
  • Undergoing laparoscopic gastric sleeve.

排除标准

  • Documented hypersensitivity to any component of the study regimen.
  • Current treatment with: Orap (pimozide), Seldane (terfenadine), Hismanal (astemizole) or Propulsid (cisapride).
  • Allergy to opioid drugs used in the anesthetic protocol.
  • Drug or alcohol abuse.
  • Chronic nausea and vomiting.
  • Previous bariatric procedures.

研究组 & 干预措施

Aprepitant

Experimental

Aprepitant (80 or 125 mg) + Ondansetron 8 mg + Metoclopramide 10 mg + Dexamethasone 8 mg

干预措施: Aprepitant (Drug)

Placebo

Placebo Comparator

Placebo + Ondansetron 8 mg + Metoclopramide 10 mg + Dexamethasone 8 mg

干预措施: Placebo (Other)

结局指标

主要结局

Patient's postoperative nausea and vomiting evaluation at 0 hrs (Rhodes index)

时间窗: 0 postoperative hours

Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhodes scale

Patient's postoperative nausea and vomiting evaluation at 6 hrs (Rhodes index)

时间窗: 6 postoperative hours

Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale

Patient's postoperative nausea and vomiting evaluation at 24 hrs (Rhodes index)

时间窗: 24 postoperative hours

Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale

Patient's postoperative nausea and vomiting evaluation at 12 hrs (Rhodes index)

时间窗: 12 postoperative hours

Change of postoperative nausea and vomiting after laparoscopic gastric sleeve using Rhoades scale

次要结局

未报告次要终点

研究者

发起方
Hospital General Tlahuac
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

CARLOS ZERRWECK LOPEZ

Professor of Surgery, UNAM

Hospital General Tlahuac

研究点 (1)

Loading locations...

相似试验